Do analysts rate CO or AUNA?

Auna has a consensus price target of $6.97, suggesting a potential upside of 32.95%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Global Cord Blood. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Do analysts rate CO or SBC?

SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 132.24%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Global Cord Blood. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend VMD or CO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Global Cord Blood (CO) Competitors

$0.95 0.00 (0.00%)

As of 08/14/2026

Compare

CO vs. CCRN, CYH, AUNA, SBC, and VMD

Should you buy Global Cord Blood stock or one of its competitors? Global Cord Blood's main competitors and comparable companies include Cross Country Healthcare (CCRN), Community Health Systems (CYH), Auna (AUNA), SBC Medical Group (SBC), and Viemed Healthcare (VMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Global Cord Blood compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market.

96.0% of Cross Country Healthcare shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Cross Country Healthcare had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Cross Country Healthcare and 0 mentions for Global Cord Blood. Cross Country Healthcare's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score.

Company	Overall Sentiment
Cross Country Healthcare	Neutral
Global Cord Blood	Neutral

Global Cord Blood has a net margin of 0.00% compared to Cross Country Healthcare's net margin of -9.84%. Global Cord Blood's return on equity of 0.00% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Global Cord Blood	N/A	N/A	N/A

Cross Country Healthcare currently has a consensus target price of $12.05, suggesting a potential downside of 9.06%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cross Country Healthcare is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Global Cord Blood has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Global Cord Blood, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49

Summary

Cross Country Healthcare and Global Cord Blood tied by winning 7 of the 14 factors compared between the two stocks.

How does Global Cord Blood compare to Community Health Systems?

Community Health Systems (NYSE:CYH) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

85.0% of Community Health Systems shares are held by institutional investors. 11.1% of Community Health Systems shares are held by insiders. Comparatively, 0.5% of Global Cord Blood shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Community Health Systems has a net margin of 2.10% compared to Global Cord Blood's net margin of 0.00%. Global Cord Blood's return on equity of 0.00% beat Community Health Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Community Health Systems	2.10%	-6.66%	0.62%
Global Cord Blood	N/A	N/A	N/A

Community Health Systems presently has a consensus price target of $2.95, indicating a potential downside of 1.83%. Given Community Health Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Community Health Systems is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Community Health Systems	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.71
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Community Health Systems' average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score.

Company	Overall Sentiment
Community Health Systems	Neutral
Global Cord Blood	Neutral

Community Health Systems has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market.

Community Health Systems has higher revenue and earnings than Global Cord Blood. Global Cord Blood is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Community Health Systems	$11.98B	0.04	$509M	$1.85	1.62
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49

Summary

Community Health Systems beats Global Cord Blood on 12 of the 14 factors compared between the two stocks.

How does Global Cord Blood compare to Auna?

Global Cord Blood (NYSE:CO) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

Auna has a consensus price target of $6.97, suggesting a potential upside of 32.95%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Global Cord Blood has higher earnings, but lower revenue than Auna. Global Cord Blood is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49
Auna	$4.52B	0.09	$27.39M	$0.26	20.15

Global Cord Blood has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market. Comparatively, Auna has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

In the previous week, Auna had 2 more articles in the media than Global Cord Blood. MarketBeat recorded 2 mentions for Auna and 0 mentions for Global Cord Blood. Auna's average media sentiment score of 0.53 beat Global Cord Blood's score of 0.00 indicating that Auna is being referred to more favorably in the news media.

Company	Overall Sentiment
Global Cord Blood	Neutral
Auna	Positive

Auna has a net margin of 1.53% compared to Global Cord Blood's net margin of 0.00%. Auna's return on equity of 16.25% beat Global Cord Blood's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Auna	1.53%	16.25%	4.03%

Summary

Auna beats Global Cord Blood on 12 of the 15 factors compared between the two stocks.

How does Global Cord Blood compare to SBC Medical Group?

Global Cord Blood (NYSE:CO) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Global Cord Blood has higher revenue and earnings than SBC Medical Group. Global Cord Blood is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49
SBC Medical Group	$175.17M	2.14	$50.99M	$0.47	7.79

SBC Medical Group has a net margin of 27.99% compared to Global Cord Blood's net margin of 0.00%. SBC Medical Group's return on equity of 18.81% beat Global Cord Blood's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
SBC Medical Group	27.99%	18.81%	13.49%

60.8% of SBC Medical Group shares are owned by institutional investors. 0.5% of Global Cord Blood shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 132.24%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

In the previous week, SBC Medical Group had 13 more articles in the media than Global Cord Blood. MarketBeat recorded 13 mentions for SBC Medical Group and 0 mentions for Global Cord Blood. SBC Medical Group's average media sentiment score of 0.09 beat Global Cord Blood's score of 0.00 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Global Cord Blood	Neutral
SBC Medical Group	Neutral

Summary

SBC Medical Group beats Global Cord Blood on 13 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Viemed Healthcare?

Viemed Healthcare (NASDAQ:VMD) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

Global Cord Blood has higher revenue and earnings than Viemed Healthcare. Global Cord Blood is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$301.61M	1.16	$14.93M	$0.36	25.56
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49

Viemed Healthcare has a net margin of 4.81% compared to Global Cord Blood's net margin of 0.00%. Viemed Healthcare's return on equity of 10.16% beat Global Cord Blood's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
Global Cord Blood	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Viemed Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

74.2% of Viemed Healthcare shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Viemed Healthcare had 3 more articles in the media than Global Cord Blood. MarketBeat recorded 3 mentions for Viemed Healthcare and 0 mentions for Global Cord Blood. Viemed Healthcare's average media sentiment score of 0.54 beat Global Cord Blood's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Viemed Healthcare	Positive
Global Cord Blood	Neutral

Summary

Viemed Healthcare beats Global Cord Blood on 12 of the 15 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CO vs. The Competition

Export

Metric	Global Cord Blood	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$115.60M	$9.81B	$7.04B	$24.30B
Dividend Yield	N/A	2.55%	2.57%	3.68%
P/E Ratio	1.49	35.17	270.72	30.85
Price / Sales	0.09	4.72	574.42	58.63
Price / Cash	4.19	124.34	70.48	32.80
Price / Book	0.15	3.94	12.92	6.82
Net Income	$79.04M	$309.96M	$3.45B	$1.06B
7 Day Performance	N/A	0.09%	1.16%	0.55%
1 Month Performance	0.11%	-0.33%	1.38%	2.90%
1 Year Performance	72.91%	19.52%	62.53%	19.10%

Global Cord Blood Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CO Global Cord Blood	N/A	$0.95 flat	N/A	+72.9%	$115.60M	$1.24B	1.49	1,202
CCRN Cross Country Healthcare	1.6206 of 5 stars	$13.25 flat	$12.05 -9.1%	N/A	$428.05M	$1.00B	N/A	6,784
CYH Community Health Systems	1.1501 of 5 stars	$3.02 +1.5%	$2.95 -2.2%	+9.9%	$425.15M	$12.49B	1.63	57,000
AUNA Auna	4.6787 of 5 stars	$5.35 +1.2%	$6.97 +30.1%	-17.6%	$396.69M	$1.23B	20.62	15,254	Upcoming Earnings
SBC SBC Medical Group	3.4248 of 5 stars	$3.46 +8.5%	$8.50 +145.7%	-9.9%	$354.93M	$173.61M	8.87	N/A	Trending News Earnings Report Analyst Forecast High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CO) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Global Cord Blood (CO) Competitors

CO vs. CCRN, CYH, AUNA, SBC, and VMD

How does Global Cord Blood compare to Cross Country Healthcare?

Summary

How does Global Cord Blood compare to Community Health Systems?

Summary

How does Global Cord Blood compare to Auna?

Summary

How does Global Cord Blood compare to SBC Medical Group?

Summary

How does Global Cord Blood compare to Viemed Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CO vs. The Competition

Global Cord Blood Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Global Cord Blood (CO) Competitors

CO vs. CCRN, CYH, AUNA, SBC, and VMD

How does Global Cord Blood compare to Cross Country Healthcare?

Which has more risk and volatility, CCRN or CO?

Do institutionals and insiders hold more shares of CCRN or CO?

Does the media prefer CCRN or CO?

Is CCRN or CO more profitable?

Do analysts prefer CCRN or CO?

Which has better valuation & earnings, CCRN or CO?

Summary

How does Global Cord Blood compare to Community Health Systems?

Do institutionals and insiders believe in CYH or CO?

Is CYH or CO more profitable?

Do analysts prefer CYH or CO?

Does the media prefer CYH or CO?

Which has more risk and volatility, CYH or CO?

Which has preferable earnings and valuation, CYH or CO?

Summary

How does Global Cord Blood compare to Auna?

Do analysts rate CO or AUNA?

Which has higher earnings & valuation, CO or AUNA?

Which has more volatility and risk, CO or AUNA?

Does the media prefer CO or AUNA?

Is CO or AUNA more profitable?

Summary

How does Global Cord Blood compare to SBC Medical Group?

Which has higher valuation and earnings, CO or SBC?

Is CO or SBC more profitable?

Do insiders & institutionals have more ownership in CO or SBC?

Do analysts rate CO or SBC?

Which has more volatility and risk, CO or SBC?

Does the media prefer CO or SBC?

Summary

How does Global Cord Blood compare to Viemed Healthcare?

Which has stronger valuation and earnings, VMD or CO?

Is VMD or CO more profitable?

Do analysts recommend VMD or CO?

Which has more volatility and risk, VMD or CO?

Do insiders & institutionals believe in VMD or CO?

Does the media favor VMD or CO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CO vs. The Competition

Global Cord Blood Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools